Search results
Pipeline. Rigorous and groundbreaking science has always been at the core of what we do at Genentech. Our R&D activities are focused on applying excellent science to discover and develop potential new medicines with the goal of becoming first-in-class or best-in-class therapeutics.
Apr 24, 2024 · Genentech Pipeline This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.
Medical Professionals / Our Pipeline KRAS G12C (GDC-6036) These compounds and their uses are investigational and have not been approved by the U.S. Food and Drug Administration.
Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind. Learn More. Quick Links. Advancing Inclusive Research. Patient Financial Support.
Genentech research and early development (gRED) Spark. 2 New to phase II New to phase III New to registration Removed from phase I Removed from phase II Removed from phase III Approvals 1 NME: RG6536 vixarelimab –IPF & SSc-ILD ... Changes to the development pipeline New to phase I Q2 2023 update 4 NMEs: RG6449 HBsAg MAb –chronic hepatitis B RG6353 HLA-G CD3 TCB –solid tumors RG6537 AR degrader –mCRPC CHU SAIL66 –solid tumors 1 NME:
Nov 28, 2023 · In its new partnership with Nvidia, Genentech plans to accelerate and optimize its machine learning (ML) algorithms and models through NVIDIA DGX™ Cloud, designed to facilitate generative AI ...
Sep 7, 2023 · As of August 31, 2023, Genentech has 13 drugs in the discovery phase, 54 drugs in the preclinical phase, and 44 drugs in phase 1 of clinical trials. This demonstrates Genentech's commitment to continuously exploring new drug candidates and advancing them through the various stages of development.
Sep 20, 2023 · Combining the PeptiDream's expertise in the field of peptide-RI conjugates, with Genentech's powerful development and commercialization capabilities.
Feb 21, 2023 · When it comes to looming commercial prospects in Genentech’s pipeline, the Roche subsidiary is armed with a plethora of late-stage cancer candidates, such as giredestrant in breast cancer.
1 day ago · About Genentech. Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. ... Target or technology pipeline and corporate benchmark analysis and assessment reports can be prepared according to the specifications of the client from the ...
